ARCHIVES

Study Would Try to Validate EGFR FISH as Predictive Marker for Benefit from Tarceva.

This article is from The Cancer Letter archive.

Vol. 33 No. 27 | July 13, 2007

Download PDF Visit The Full Archive

Related Articles

Cooperative Groups Not Included Among Grants to Be Funded At Recommended Levels

November 11, 1983

NIH Backs Down Agrees Nurses May Be Hired Into Commissioned Corps

June 13, 1986

NCI Would Fund 1,052 Competing Grants In Fy95

February 11, 1994

Recombinant TSH Avoids Need To Stop Replacement Therapy

January 27, 2006

Proposed HHS Conflict of Interest Rules May Require More Disclosure by Researchers

May 15, 2009

Ibrutinib Increases OS, PFS Versus Ofatumumab in Phase III

June 27, 2014